Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Yahoo! Finance
Adjusted Gross Margin: 73.1% for Q3 2024, up from 72.5% in Q3 2023. Operating Expenses: $26 million for Q3 2024, down from $27.8 million in Q3 2023. Operating Loss: $15.4 million for Q3 2024, an improvement of 7% from Q3 2023. Adjusted Operating Loss: $10.6 million for Q3 2024, an improvement of 10% from Q3 2023. Cash Burn: $9.6 million for Q3 2024, a 39% improvement from the prior year quarter. Cash and Cash Equivalents: Approximately $95.8 million as of September 30, 2024. Customer Count: 462 as of September 30, 2024, up from 431 in the prior year period. Net Dollar Retention: 109% for Q3 2024, compared to 127% in Q3 2023. Annualized Revenue Churn Rate: Less than 4% for Q3 2024. Clinical Volume: Approximately 91,000 analyses for Q3 2024, a 16% year over year growth. Warning! GuruFocus has detected 2 Warning Signs with SOPH. Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript So
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- SOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesPR Newswire
- SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- SOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesPR Newswire
- SOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesPR Newswire
- SOPHiA GENETICS SA (NASDAQ: SOPH) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $11.00 price target on the stock.MarketBeat
SOPH
Earnings
- 11/5/24 - Miss
SOPH
Sec Filings
- 1/27/25 - Form 144
- 1/27/25 - Form 144
- 1/24/25 - Form 144
- SOPH's page on the SEC website